Abstract:Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, has long been thought to exert its benefits by reducing cholesterol synthesis, and has been shown to significantly reduce cardiovascular events and mortality in patients with or without coronary artery disease. However, it is still unknown whether acute administration of simvastatin beneficially affects the cardiac function prior or during ischemia–reperfusion. The aim of this study is to evaluate the cardioprotective effect of acute simvastatin treatment on isolated rat hearts or isolated ischemia–reperfusion hearts. Hearts were isolated from male Sprague–Dawley rats and attached to a Langendorff apparatus. The isolated hearts with or without ischemia (15 min) and reperfusion (60 min) were perfused with different concentrations of simvastatin. The parameters of cardiac function (such as left ventricular developed pressure [LVDP], +d p /d t max, and −d p /d t max), heart rate, and coronary flow were recorded. Simvastatin (3–30 µmol/l) significantly increased LVDP, +d p /d t max, and −d p /d t max in isolated rat hearts perfused for 60 min. Heart rate was depressed by 30 µmol/l simvastatin and the coronary flow was increased by 10 and 30 µmol/l simvastatin. At a concentration of 100 µmol/l simvastatin, worsening of heart function and subsequent cardiac arrest occurred. Administration of simvastatin (3–30 µmol/l) significantly preserved cardiac function detected by LVDP, +d p /d t max, and −d p /d t max in the isolated ischemia/reperfused (15/60 min) rat hearts. Simvastatin also significantly decreased heart rate at 30 µmol/l, and increased coronary flow at 10 and 30 µmol/l in these rat hearts. However, the protective effect of simvastatin reverted to increased damage at 100 µmol/l. Only 3 µmol/l simvastatin pretreatment before 15/60 min ischemia–reperfusion altered LVDP, +d p /d t max, and −d p /d t max. Both heart rate and coronary flow were unaltered after simvastatin pretreatment. Since simvastatin at a concentration lower than 100 µmol/l exerted beneficial effects on cardiac function in isolated perfused rat hearts, it could be applied just after myocardial ischemia and reperfusion.

Effect of Simvastatin on Endothelium-Dependent Vaso-Relaxation and Endogenous Nitric Oxide Synthase Inhibitor

Effects of simvastatin on cardiohemodynamic responses to ischemia–reperfusion in isolated rat hearts

Effects of Simvastatin on Cardiac Performance and Expression of Sarco-Plasmic Reticular Calcium Regulatory Proteins in Rat Heart

[Effects of Atorvastatin on Endothelium Protection in Spontaneously Hypertensive Rats].

The Inhibitory Effect of Simvastatin on the ADMA-induced Inflammatory Reaction is Mediated by MAPK Pathways in Endothelial Cells.

The Effects of Simvastatin on Endothelial Cells Scretings of NO、NOS

Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats

Aspirin Protected Against Endothelial Damage Induced by LDL： Role of Endogenous NO Synthase Inhibitors in Rats

Effect of Simvastatin on the Proliferation and Migration of Vascular Smooth Muscle Cells

Effect of simvastatin on cholesterol efflux and expression of ABCA1 and CD36 in THP-1 macrophages

The Protective Effects of Simvastatin on Lipopolysaccharide-Induced Endothelial Cell Injury

Effect of Fenofibrate on LDL-induced Endothelial Dysfunction in Rats

The effect of simvastatin on the serum monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 levels in diabetic rats

Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein

Effect of Simvastatin on Regression of Pressure Overload-Induced Rat's Myocardial Fibrosis and Its Relationship with Monocyte Chemoattractant Protein-1

Effect of simvastatin on the level of monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 in diabetic rats

17Β-Estradiol Preserves Endothelial Function by Reduction of the Endogenous Nitric Oxide Synthase Inhibitor Level

Effects of Simvastatin on Blood Lipids, Von Willebrand Factor and Endothelin in Coronary Heart Disease

[Multiple Effect of Simvastatin on Vascular Endothelium of Hypercholesterolemia Patients].

Simvastatin Attenuates the Additive Effects of TNF-α and IL-18 on the Connexin 43 Up-Regulation and Over-Proliferation of Cultured Aortic Smooth Muscle Cells.

Simvastatin Ameliorates Renal Lipidosis Through The Suppression Of Renal Cxcl16 Expression In Mice With Adriamycin-Induced Nephropathy